Upgrade to SI Premium - Free Trial

Teva Pharma (TEVA) PT Raised to $45 at Truist Securities

April 29, 2026 3:23 PM
Truist Securities analyst Les Sulewski raised the price target on Teva Pharma (NYSE: TEVA) to $45.00 (from $42.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change